Company: BIAF
Filing Date: 2025-04-15
Form Type: PRE 14A
Source: 0001641172-25-004857
Chunk: 64

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-04-15
Form: PRE 14A
Chunk 64
---
 relation to the disclosure of material nonpublic information, the Compensation Committee does not seek to time equity grants to take advantage of information, either positive or negative, about our company that has not been publicly disclosed. It has been our practice to grant equity awards to our officers and directors upon their appointment. We intend to issue equity grants to our officers and directors at the same time each year. It is our policy to grant our executive officers annual equity awards of restricted stock in the first quarter of each year and to grant our directors annual equity awards of restricted stock on July 1 of each year. Option grants, if any, are effective on the date the award determination is made by the Compensation Committee, and the exercise price of options is the closing market price of our Common Stock on the business day of the grant or, if the grant is made on a weekend or holiday, on the prior business day.

During the fiscal year ended December 31, 2024, we did not award any options to a named executive officer, and we did not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.

| 34 |

Outstanding Equity Awards at December 31, 2024

The table below summarizes the outstanding equity awards awarded to the Company’s NEOs during the fiscal year ended December 31, 2024.

|                    |     |            |     |                                                       Option Awards |     |                                                                       |     |                           |     |                        |     |                                                Stock Awards |     |                                                                   |
| Name               |     | Grant Date |     | Number of Securities Underlying Unexercised Options (#) Exercisable |     | Number of Securities Underlying Unexercised Options (#) Unexercisable |     | Option Exercise Price ($) |     | Option Expiration Date |     | Number of Shares or Units of Stock That Have Not Vested (#) |     | Market Value of Shares of Units of Stock That Have Not Vested ($) |
| Maria Zannes       |     | 7/27/2015  |     |                                                               3,571 |     | —                                                                     |     |                      4.20 |     | 7/26/2025              |     |                                                           — |     |                                                                 — |
|                    |     | 7/25/2016  |     |                                                               3,571 |     | —                                                                     |     |                      7.00 |     | 7/24/2026              |     |                                                           — |